E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/28/2014 in the Prospect News Bank Loan Daily.

Bioplan/Arcade Marketing to launch $585 million facility on Aug. 4

By Sara Rosenberg

New York, July 28 – Bioplan/Arcade Marketing is scheduled to hold a bank meeting on Aug. 4 to launch a $585 million credit facility, according to a market source.

The facility consists of a $65 million revolver, a $375 million seven-year first-lien term loan and a $145 million eight-year second-lien term loan, the source said.

Goldman Sachs Bank USA, Credit Suisse Securities (USA) LLC, Barclays and Deutsche Bank Securities Inc. are the lead banks on the deal, with Goldman left lead on the first-lien loan and Credit Suisse left lead on the second-lien loan.

Proceeds will be used to fund the merger of Bioplan and Arcade Marketing.

Bioplan is owned by Ileos, which is owned by Oaktree Capital Management LP, and Arcade Marketing is owned by Visant Corp., which is controlled by KKR and DLJ Merchant Banking.

Under the agreement, Oaktree would retain a 75% ownership interest and KKR/DLJ Merchant would retain a 25% ownership interest in the combined company.

Closing is expected by the beginning of the fourth quarter, subject to customary conditions and regulatory reviews.

Bioplan is a provider of unit-dose sampling and promotional turnkey solutions. Arcade Marketing is a New York-based provider of sampling solutions for the fragrance, cosmetics and skincare segments.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.